4//SEC Filing
ENGLE STEVEN B 4
Accession 0001209191-03-030002
CIK 0000920465other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:07 PM ET
Size
12.3 KB
Accession
0001209191-03-030002
Insider Transaction Report
Form 4
ENGLE STEVEN B
DirectorCEO & Chairman
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2003-11-10$1.00/sh−10,000$10,000→ 2,480,000 totalExercise: $1.00Exp: 2004-02-02→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Options (right to buy)
2003-11-11$1.00/sh−31,000$31,000→ 2,449,000 totalExercise: $1.00Exp: 2004-02-02→ Common Stock (31,000 underlying) - Exercise/Conversion
Common Stock
2003-11-10$1.00/sh+100,000$100,000→ 101,484 total - Exercise/Conversion
Common Stock
2003-11-10$1.00/sh+10,000$10,000→ 111,484 total - Sale
Common Stock
2003-11-10$3.02/sh−110,000$332,200→ 1,484 total - Exercise/Conversion
Common Stock
2003-11-11$1.00/sh+31,000$31,000→ 32,484 total - Sale
Common Stock
2003-11-11$2.93/sh−31,000$90,830→ 1,484 total - Exercise/Conversion
Stock Options (right to buy)
2003-11-10$1.00/sh−100,000$100,000→ 2,490,000 totalExercise: $1.00Exp: 2004-01-04→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 30, 2002, and amended on October 1, 2003.
- [F2]Stock options became fully vested and exercisable on 01/04/1998.
- [F3]Stock options became fully vested and exercisable on 02/02/1997.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001234368
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 6:07 PM ET
- Size
- 12.3 KB